The Mississauga Support Group To Host Annual Fundraiser PDF Print E-mail
Thursday, 03 March 2011 22:41
The Mississauga Support Group of the Scleroderma Society of Ontario will host its annual fundraising dinner and dance gala on April 2 at the Oasis Convention Centre. Funds raised will go to the Scleroderma Society of Ontario to fund research, improve patient care and raise public awareness of the chronic, progressive autoimmune disease of the connective tissue, which generally causes a hardening of the skin.
Those living with the illness, which usually strikes women between the ages of 30 and 50, also experience poor circulation and skin discolouration, a hardening of internal organs, reduced finger function and difficulty with movement and swallowing. Since its inception, the gala has raised $236,000. This year's event will include a reception and raffle as well as live and silent auctions, plus dinner. Tickets cost $75 and come with a $50 charitable tax receipt. Call 905-822-7868, 905-990-4598, 905-826-3961 or 905-824-2305. Scleroderma affects hundreds of people in Ontario and about 16,000 across Canada.
Scleroderma Awareness Month takes place each June.
The Mississauga Support Group of the Scleroderma Society of Ontario will host its annual fundraising dinner and dance gala on April 2 at the Oasis Convention Centre. Funds raised will go to the Scleroderma Society of Ontario to fund research, improve patient care and raise public awareness of the chronic, progressive autoimmune disease of the connective tissue, which generally causes a hardening of the skin. Those living with the illness, which usually strikes women between the ages of 30 and 50, also experience poor circulation and skin discolouration, a hardening of internal organs, reduced finger function and difficulty with movement and swallowing.  

Since its inception, the gala has raised $236,000. This year's event will include a reception and raffle as well as live and silent auctions, plus dinner. Tickets cost $75 and come with a $50 charitable tax receipt. Call 905-822-7868, 905-990-4598, 905-826-3961 or 905-824-2305. Scleroderma affects hundreds of people in Ontario and about 16,000 across Canada. 

Scleroderma Awareness Month takes place each June.
 
More articles :

» Jefferson Researchers Identify Mechanism Behind Fibrotic Disorder

Scientists from the of Thomas Jefferson University are now several steps closer to understanding the mechanism behind a novel systemic fibrotic disorder that affects some patients with renal insufficiency who receive imaging contrast agents for...

» Treatment for Pulmonary Arterial Hypertension Cleared

has recently reported in its that the FDA has cleared Tyvaso (treprostinil) Inhalation Solution for the treatment of pulmonary arterial hypertension (PAH). Developed by United Therapeutics Corp., of Silver Spring, Md., treprostinil is indicated to...

» Children Get Scleroderma Too

Juvenile is a rare childhood condition characterized by fibrosis of the skin and internal organs. Clinical manifestations of childhood Scleroderma are different from adult disease and early recognition, correct classification and treatment can...

» New Formulation of PAH Medication Is Now Available

Epoprostenol for Injection, an improved formulation of epoprostenol that is stable at room temperature, is now commercially available, according to the drug's maker, Actelion Pharmaceuticals US, Inc., of South San Francisco, Calif.The product is...

» Study Indicates Scleroderma Mortality Rates Being Underestimated

patients have a significantly reduced life expectancy that is most likely being underestimated, delegates have heard. Most studies on scleroderma survival are based on prevalent cohorts, where no limit is placed on disease duration at the time of...

» Rituximab for Scleroderma: Does Something Finally Work?

Kevin Deane, MDPosted: 03/10/2010Experience With Rituximab in Scleroderma: Results From a 1-Year, Proof-of-Principle StudyDaoussis D, Liossis SN, Tsamandas AC, et al. Rheumatology (Oxford). 2010;49:271-280BackgroundMultiple drugs have been tried in...